arrow_back Back to App

Increased Awareness of Kidney Cancer in Individuals with Sickle Cell Disease

This act aims to increase awareness of renal medullary carcinoma in individuals with sickle cell disease who receive medical assistance. This will provide these individuals with better access to information about the risk of this disease, potentially aiding in early detection and treatment. These changes are intended to improve citizens' health and safety.
Key points
The act provides incentives for education on the risk of renal medullary carcinoma for individuals with sickle cell disease under Medicaid.
The goal is to increase awareness and early detection, which can improve treatment outcomes.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_124
Sponsor: Rep. Green, Al [D-TX-9]
Process start date: 2025-01-03
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_124.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-01-03.

What are the main provisions?

Key points include:

  • The act provides incentives for education on the risk of renal medullary carcinoma for individuals with sickle cell disease under Medicaid.
  • The goal is to increase awareness and early detection, which can improve treatment outcomes.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Green, Al [D-TX-9].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health Benefits